Log in

Relevant bibliographies by topics / Jpsat / Journal articles

To see the other types of publications on this topic, follow the link: Jpsat.

Journal articles on the topic 'Jpsat'

Author: Grafiati

Published: 25 July 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Jpsat.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lohan, Elena Simona. "Emerging Topics in Joint Radio-Based Positioning, Sensing, and Communications." Sensors 25, no. 3 (2025): 948. https://doi.org/10.3390/s25030948.

Full text

Abstract:

This is an editorial paper focusing on emerging topics in joint wireless positioning, sensing, and communications. After introducing the sometimes-confusing and non-unified terminology in the field and defining the overall research area under the comprehensive terminology of Joint positioning, sensing, and communications (JPSAC), a brief state-of-the art overview is given, followed by a detailed list of emerging topics and open research questions. The ongoing Horizon Europe projects are also reviewed in relation to the emerging JPSAC. Some of the main trends in the JPSAC-related areas are rela

APA, Harvard, Vancouver, ISO, and other styles

2

Kume, Ikuo. "The 2004 JPSA-APSA Exchange." PS: Political Science & Politics 38, no. 1 (2005): 164. http://dx.doi.org/10.1017/s1049096505056210.

Full text

Abstract:

In 1990, the Japanese Political Science Association (JPSA) and the APSA initiated a formal exchange program. Every year, the JPSA invites APSA representatives to attend our annual meeting—where they have a joint session with Japanese members—and sends two JPSA representatives to the APSA Annual Meeting. In 2004, APSA President Margaret Levi (University of Washington) and Ian Shapiro (Yale University) attended the JPSA meeting in Sapporo; the JPSA exchange participants in the APSA Annual Meeting in Chicago were Ryosuke Amiya (Kobe University) and Kensuke Takayasu (Hokkaido University).

APA, Harvard, Vancouver, ISO, and other styles

3

Hu, Shuli, Daniel D. Harabor, Graeme Gange, Peter J. Stuckey, and Nathan R. Sturtevant. "Multi-Agent Path Finding with Temporal Jump Point Search." Proceedings of the International Conference on Automated Planning and Scheduling 32 (June 13, 2022): 169–73. http://dx.doi.org/10.1609/icaps.v32i1.19798.

Full text

Abstract:

Temporal Jump Point Search (JPST) is a recently introduced algorithm for grid-optimal pathfinding among dynamic temporal obstacles. In this work we consider JPST as a low-level planner in Multi-Agent Path Finding (MAPF). We investigate how the canonical ordering of JPST can negatively impact MAPF performance and we consider several strategies which allow us to overcome these limitations. Experiments show our new CBS/JPST approach can substantially improve on CBS/SIPP, a contemporary and leading method from the area.

APA, Harvard, Vancouver, ISO, and other styles

4

BUTBUL, YONATAN AVIEL, PASCAL N. TYRRELL, RAYFEL SCHNEIDER, et al. "Comparison of Patients with Juvenile Psoriatic Arthritis and Nonpsoriatic Juvenile Idiopathic Arthritis: How Different Are They?" Journal of Rheumatology 36, no. 9 (2009): 2033–41. http://dx.doi.org/10.3899/jrheum.080674.

Full text

Abstract:

Objective.To compare the clinical features and outcome between patients with juvenile psoriatic arthritis (JPsA) and non-JPsA juvenile idiopathic arthritis (JIA).Methods.Fifty-three children with JPsA, 32 with < 5 joints in the first 6 months of disease (oligo–JPsA) and 21 (≥ 5 joints) polyarticular-onset (poly-JPsA) were compared to 53 patients with JIA who were matched by sex, age, date of diagnosis, and articular onset pattern.Results.There was no difference in the percentage of patients between the oligoarticular groups who developed extended oligoarthritis or in the percentage of patie

APA, Harvard, Vancouver, ISO, and other styles

5

Low, J. M. J., K. Hyrich, N. Geifman, and S. Shoop-Worrall. "POS1309 THE IMPACT OF PSORIASIS ON PATIENT-REPORTED OUTCOMES IN JUVENILE PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases 81, Suppl 1 (2022): 992.2–993. http://dx.doi.org/10.1136/annrheumdis-2022-eular.2715.

Full text

Abstract:

BackgroundChildren with juvenile psoriatic arthritis (JPsA) are treated similarly to patients in other categories of juvenile idiopathic arthritis (JIA) despite distinctive clinical features, including either a personal or family history of psoriasis. It remains unknown whether the unique features in JPsA lead patients to experience the impact of disease differently from other JIA patients, and how the presence of psoriasis within JPsA affects patient outcomes. These gaps in our knowledge suggest there may be unmet treatment needs in these children and young people.ObjectivesTo compare patient

APA, Harvard, Vancouver, ISO, and other styles

6

Zisman, Devy, Dafna D. Gladman, Matthew L. Stoll, et al. "The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes." Journal of Rheumatology 44, no. 3 (2017): 342–51. http://dx.doi.org/10.3899/jrheum.160717.

Full text

Abstract:

Objective.Children with clinically diagnosed juvenile psoriatic arthritis (JPsA) who were enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry (CARRA-JPsA) were classified according to pediatric International League of Associations for Rheumatology (ILAR) and adult criteria [Classification criteria for Psoriatic Arthritis (CASPAR)]. Data on demographic and clinical features at baseline and 1-year followup were analyzed and compared.Methods.Cross-sectional analysis was performed of CARRA-JPsA patients enrolled between May 2010 and December 2013 and stratified

APA, Harvard, Vancouver, ISO, and other styles

7

Samad, Aaida, Matthew L. Stoll, Idit Lavi, et al. "Adiposity in Juvenile Psoriatic Arthritis." Journal of Rheumatology 45, no. 3 (2017): 411–18. http://dx.doi.org/10.3899/jrheum.170598.

Full text

Abstract:

Objective.Adult patients with psoriatic arthritis are at increased risk for obesity and metabolic syndrome, but data regarding adiposity in children with juvenile psoriatic arthritis (JPsA) are limited. Our study assessed adiposity in children with JPsA in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.Methods.Patients with JPsA in the CARRA registry were divided into nonoverweight and overweight groups using recommendations from the US Centers for Disease Control, and differences in demographic and clinical characteristics between groups at baseline and after 1-ye

APA, Harvard, Vancouver, ISO, and other styles

8

Butbul, Y. "OP0305 VALIDATION OF THE PSORIASIS EPIDEMIOLOGY SCREENING TOOL (PEST) AND THE NEW EARLY ARTHRITIS FOR PSORIATIC PATIENTS (EARP) IN PEDIATRIC POPULATION - PILOT STUDY." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 187.2–187. http://dx.doi.org/10.1136/annrheumdis-2021-eular.4165.

Full text

Abstract:

Background:Juvenile Psoriatic Arthritis (JPsA) is an inflammatory arthritis associated with irreversible joint damage among the pediatric population, which is associated with psoriasis in most cases.While there are few validated screening tools for diagnosis of arthritis for adult patients with psoriasis, those screening tools were never evaluated in children.Objectives:The aims of this study were to evaluate two screening tools among pediatric patients with psoriasis.Methods:Thirty-nine patients with the diagnosis of psoriasis were administered two screening questionnaires: the new Early Arth

APA, Harvard, Vancouver, ISO, and other styles

9

Naddei, Roberta, Ana Rebollo-Giménez, Marco Burrone, et al. "Juvenile Psoriatic Arthritis: Myth or Reality? An Unending Debate." Journal of Clinical Medicine 12, no. 1 (2023): 367. http://dx.doi.org/10.3390/jcm12010367.

Full text

Abstract:

Juvenile psoriatic arthritis (JPsA) accounts for 1–7% of all cases of juvenile idiopathic arthritis (JIA) and its definition has been a matter of controversy among pediatric rheumatologists for many years. The traditional attribution of JPsA to the spondyloarthropathy group was challenged in the early 1990s, whereas the recent demonstrations of its heterogenous nature have led to questions about its identification as a distinct category in JIA classification. It has been shown that children with the phenotype of JPsA can be divided in two subgroups, one presenting with the features of early-on

APA, Harvard, Vancouver, ISO, and other styles

10

Morris, Walter. "PDA JPST Online Reboot." PDA Journal of Pharmaceutical Science and Technology 73, no. 5 (2019): 417. http://dx.doi.org/10.5731/pdajpst.2019.001115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Shoop-Worrall, S., C. Ciurtin, G. Cleary, et al. "POS0742 CLUSTERS OF JUVENILE PSORIATIC ARTHRITIS IDENTIFIED AT INITIAL PRESENTATION TO PAEDIATRIC RHEUMATOLOGY IN A NATIONWIDE UK COHORT." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 661.1–661. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2282.

Full text

Abstract:

BackgroundThe heterogenous presentation and variable clinical response of juvenile psoriatic arthritis (JPsA) to disease-modifying therapies suggests undiscovered subgroups within this disease. Nevertheless, JPsA is often studied under the umbrella of juvenile idiopathic arthritis (JIA), with few studies interrogating JPsA separately. To improve stratified treatment of this rare disease, such subgroups must be uncovered.ObjectivesTo identify novel, phenotypically consistent subgroups of children and young people (CYP) with JPsA at the point of first contact with paediatric rheumatology.Methods

APA, Harvard, Vancouver, ISO, and other styles

12

Aleksanyan, K., S. Chebysheva, O. Sukhovyova, and E. Zholobova. "OP0306 ETANERCEPT AND ADALIMUMAB IN THE TREATMENT OF JUVENILE PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 187.1–188. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2827.

Full text

Abstract:

Background:Juvenile psoriatic arthritis (JPsA) accounts for 4 to 9% of children with juvenile arthritis (1). Biologics, particularly TNF-α inhibitors, have proved to be effective and safe for treatment of psoriatic arthritis in adults (2). However, no comprehensive evidence exists on the comparative effectiveness and safety of TNF-α inhibitors in the treatment of JPsA, which challenges a decision of what biologic should be prescribed to children with JPsA.Objectives:To study the comparative effectiveness of etanercept and adalimumab in patients with JPsA with respect to both the articular and

APA, Harvard, Vancouver, ISO, and other styles

13

Iida, Hidekazu, Shinu Hayashi, Masakazu Yasunaka, et al. "Patient-centred care and quality of life and hope among Japanese patients receiving home medical care: a multicentre, cross-sectional study." BMJ Open 15, no. 1 (2025): e089639. https://doi.org/10.1136/bmjopen-2024-089639.

Full text

Abstract:

ObjectivesPatient-reported outcomes reflecting quality of life (QOL) and hope are essential targets for in-home medical care. This study examined the association between the quality of patient-centred care and both QOL and hope.DesignMulticentre, cross-sectional study.SettingTwenty-nine home care clinics in the Tokyo Metropolitan Area, Nara Prefecture and Nagasaki Prefecture in Japan.Participants200 patients receiving home medical care.ExposurePatient-centredness was measured using the Japanese version of the Primary Care Assessment Tool-Short Form (JPCAT-SF).Outcome measuresThe primary outcom

APA, Harvard, Vancouver, ISO, and other styles

14

Correll, Colleen K., Scott Stryker, David Collier, et al. "Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry." RMD Open 9, no. 2 (2023): e002943. http://dx.doi.org/10.1136/rmdopen-2022-002943.

Full text

Abstract:

ObjectiveEtanercept is commonly used to treat juvenile idiopathic arthritis, including juvenile psoriatic arthritis (JPsA); however, information on etanercept’s safety and effectiveness in clinical practice is limited. We used data from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry to evaluate etanercept’s safety and effectiveness in JPsA in clinical practice.MethodsWe analysed safety and effectiveness data for paediatric patients enrolled in the CARRA Registry who had a JPsA diagnosis and had used etanercept. Safety was assessed by calculating rates of prespecifi

APA, Harvard, Vancouver, ISO, and other styles

15

Chen, Xin, Lisi Cha, Zhi Xuan, and Weiming Zhang. "The effect of joint position sense therapy on chronic shoulder pain with central sensitization." Medicine 103, no. 15 (2024): e37786. http://dx.doi.org/10.1097/md.0000000000037786.

Full text

Abstract:

Background: Chronic shoulder pain is a common musculoskeletal problem associated with unreleased pain and functional dysfunction that can evolve into central sensitization. Some forms of manual therapy may exacerbate pain and central sensitization. This study investigated the impact of joint position sense therapy (JPST), a moderate joint proprioception training technique, on central sensitization, shoulder functional dysfunction, and pain in patients with chronic shoulder pain compared with more intense exercises or aggressive manual therapies. Methods: We assessed the pressure pain threshold

APA, Harvard, Vancouver, ISO, and other styles

16

Ferejohn, John, and Frances Rosenbluth. "The 2003 APSA-JPSA Exchange." PS: Political Science & Politics 37, no. 1 (2004): 162–64. http://dx.doi.org/10.1017/s1049096504004044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Stoll, Matthew L., and Peter A. Nigrovic. "Subpopulations Within Juvenile Psoriatic Arthritis: A Review of the Literature." Clinical and Developmental Immunology 13, no. 2-4 (2006): 377–80. http://dx.doi.org/10.1080/17402520600877802.

Full text

Abstract:

The presentation of juvenile psoriatic arthritis (JPsA) has long been recognized to be clinically heterogeneous. As the definition of JPsA expanded to accommodate atypical manifestations of psoriasis in young children, studies began to reflect an increasingly clear biphasic distribution of age of onset, with peaks in the first few years of life and again in early adolescence. These two subpopulations differ in gender ratio, pattern of joint involvement, laboratory findings and potentially response to therapy. Intriguingly, a similar distribution of age of onset has been observed in juvenile rh

APA, Harvard, Vancouver, ISO, and other styles

18

Chebysheva, Svetlana Nikolaevna, Elena Spartakovna Zholobova, Natalya Anatolevna Geppe, et al. "The Diverse and Heterogeneous Clinical Features of Juvenile Psoriatic Arthritis." Serbian Journal of Experimental and Clinical Research 22, no. 4 (2021): 351–56. http://dx.doi.org/10.2478/sjecr-2021-0066.

Full text

Abstract:

Abstract Juvenile Psoriatic Arthritis (JPsA) is a chronic inflammatory disorder that accounts for 3-10% of all juvenile arthritis. The main objective is to identify the clinical features of psoriatic arthritis in children. This study was open-label, single-center, prospective, observational (1989-2020) cohort clinical study included 85 patients (3-17.0 y/o) who met Vancouver and I/E criteria. The features of skin and articular syndromes in children with JPsA were revealed. In most patients with PSA, the disease began at the age of 6.6 years. In childhood, arthritis is usually preceded by psori

APA, Harvard, Vancouver, ISO, and other styles

19

Aleksanyan, K., S. Chebysheva, A. Meleshkina, E. Popova, and E. Zholobova. "AB0999 HALLMARK CLINICAL FEATURES of JUVENILE PSORIATIC ARTHRITIS (JPSA)." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 1792.1–1793. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1275.

Full text

Abstract:

Background:JPsA is presented in 4 to 9% children with juvenile arthritis [1,2]. According to ILAR criteria, patients with uveitis, HLA-B27-positivity, and other exclusion criteria cannot be included in the JPsA category. Therefore, in pediatric rheumatological practice, the Vancouver criteria are more often used [3].Objectives:to identify clinical features of psoriatic arthritis in children.Methods:a single center, prospective and retrospective, continuous clinical trial for the period from 1989 to 2019 was conducted.Results:We observed 83 patients with JPsA aged from 4 months to 17 years. Fif

APA, Harvard, Vancouver, ISO, and other styles

20

Aoki, Takuya, Yasuki Fujinuma, and Masato Matsushima. "Associations of primary care structures with polypharmacy and patient-reported indicators in patients with complex multimorbidity: a multicentre cross-sectional study in Japan." BMJ Open 12, no. 1 (2022): e054348. http://dx.doi.org/10.1136/bmjopen-2021-054348.

Full text

Abstract:

ObjectivesEvidence supporting the effects of primary care structures on the quality of care for patients with complex multimorbidity, which is one of the most important challenges facing primary care, is scarce internationally. This study aimed to examine the associations of the types of primary care facilities with polypharmacy and patient-reported indicators in patients with complex multimorbidity, with a focus on differences between community clinics and hospitals.DesignMulticentre cross-sectional study.SettingA total of 25 primary care facilities (19 community clinics and 6 small- and medi

APA, Harvard, Vancouver, ISO, and other styles

21

Weisberg, Herb, and Clyde Wilcox. "APSA/JPSA Exchange: A Continuing Tradition." PS: Political Science & Politics 30, no. 02 (1997): 245–46. http://dx.doi.org/10.1017/s1049096500043559.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Haas, J. P., and R. Häfner. "Juvenile Psoriasis-Arthritis." Arthritis und Rheuma 30, no. 03 (2010): 164–70. http://dx.doi.org/10.1055/s-0037-1618015.

Full text

Abstract:

ZusammenfassungDie juvenile Psoriasis-Arthritis (jPsA) wird als eine Kategorie der juvenilen idiopathischen Arthritis (JIA) definiert und weist unterschiedliche klinische Manifestationsformen auf. Die größte Gruppe bilden Patienten mit einer asymmetrischen Arthritis im Schulalter, gefolgt von Kindern mit Oligoarthritis und Beginn im Kleinkindalter. Bei zehn bis 20 Prozent besteht eine symmetrische Polyarthritis. In der Klassifikation nach ILAR von 2002 gelten Ausschlusskriterien, die insbesondere Jungen mit einer Spondylarthropathie betreffen. Dadurch ergeben sich Schwierigkeiten im Vergleich

APA, Harvard, Vancouver, ISO, and other styles

23

Turoňová, Lenka, Kristína Kubejová, Karolína Vorčáková, Peter Ďurdík, Tatiana Péčová, and Klára Martinásková. "Endothelial Dysfunction in Children with Juvenile Psoriatic Arthritis." Acta Medica (Hradec Kralove, Czech Republic) 61, no. 3 (2018): 79–85. http://dx.doi.org/10.14712/18059694.2018.122.

Full text

Abstract:

Background: To evaluate the presence of endothelial dysfunction in Slovak children with juvenile psoriatic arthritis in the absence of classic cardiovascular risk factors in order to assess its relationship to the disease activity and disability. Methods: 25 juvenile psoriatic arthritis patients (JPSA) and 25 healthy controls aged 6–19 years were enrolled into this study. In all subjects vascular measurements over a period of three years (January 2013 – January 2016) were performed, in accordance with the guidelines for ultrasonographic evaluation of FMD% (flow-mediated endothelial dependent v

APA, Harvard, Vancouver, ISO, and other styles

24

Facharztmagazine, Redaktion. "EU-Zulassung für Secukinumab bei EAA und jPSA." Orthopädie & Rheuma 25, no. 4 (2022): 51. http://dx.doi.org/10.1007/s15002-022-3607-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Butbul Aviel, Yonatan, Pascal Tyrrell, Rayfel Schneider, et al. "Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?" Pediatric Rheumatology 11, no. 1 (2013): 11. http://dx.doi.org/10.1186/1546-0096-11-11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Chow, J., and L. Bennett. "Pre-training assessment tool (JPAT) - A pilot study." EDTNA-ERCA Journal 27, no. 1 (2001): 37–41. http://dx.doi.org/10.1111/j.1755-6686.2001.tb00134.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Facharztmagazine, Redaktion. "Positive CHMP-Empfehlung für Tofacitinib bei JIA und JPsA." Orthopädie & Rheuma 24, no. 4 (2021): 63. http://dx.doi.org/10.1007/s15002-021-3329-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Chow, J. "A PRE-TRAINING ASSESSMENT TOOL FOR HOME DIALYSIS (JPAT)." EDTNA-ERCA Journal 31, no. 1 (2005): 19–23. http://dx.doi.org/10.1111/j.1755-6686.2005.tb00384.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Downs, William M. "APSA-JPSA Exchange: Building Bridges from Boston to Matsuyama." Political Science and Politics 36, no. 01 (2003): 112. http://dx.doi.org/10.1017/s1049096503001847.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Palmou-Fontana, N., I. Calvo, G. Diaz Cordoves Rego, et al. "AB1417 HOW TO DIAGNOSE: JUVENILE PSORIATIC ARTHRITIS. MULTICENTER PROSPECTIVE OBSERVATIONAL STUDY IN CHILDREN WITH SUSPECTED DIAGNOSIS." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 1937.1–1937. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1883.

Full text

Abstract:

BackgroundJuvenile psoriatic artritis (JPSA), a subtype of juvenile idiopathic arthritis (JIA), constitutes 5% of JIA. The literature is inconsistent regarding features of JPSA, and physicians debate whether it is a distinct entity within JA. Moreover, the criteria diagnosis for JPsA is currently in debate.There are two pediatric diagnostic classifications based on clinical criteria: ILAR classification criteria and Vancouver classification criteria. Classification of JIA has been a great debate since this entity disappeared. [1] The CASPAR criteria are standard in adults. These criteria have

APA, Harvard, Vancouver, ISO, and other styles

31

Nieves-Ríos, Christian, Guillermo A. Requejo Figueroa, Sofía C. Ayala Rodríguez, et al. "Bilateral Granulomatous Iridocyclitis Associated with Early-Onset Juvenile Psoriatic Arthritis." Case Reports in Ophthalmological Medicine 2022 (October 7, 2022): 1–5. http://dx.doi.org/10.1155/2022/3990406.

Full text

Abstract:

Purpose. The purpose of this study is to report on a case of bilateral granulomatous iridocyclitis in a patient with early-onset juvenile psoriatic arthritis (JPsA). Methods. The method used is an observational case report. Observations. A 3-year-old Hispanic girl was sent to our uveitis service for further evaluation of her granulomatous uveitis. The initial ophthalmologic examination revealed bilateral band keratopathy, large mutton-fat keratic precipitates, multiple posterior synechiae, and 4+ anterior chamber cells. The physical exam was notable for left knee edema and right axillary rash.

APA, Harvard, Vancouver, ISO, and other styles

32

Minden, K., C. Sengler, and N. Brüggemann. "Die juvenile Psoriasis-Arthritis." Arthritis und Rheuma 37, no. 06 (2017): 411–17. http://dx.doi.org/10.1055/s-0038-1624231.

Full text

Abstract:

ZusammenfassungDie juvenile Psoriasis-Arthritis (jPsA), eine Subgruppe der juvenilen idiopathischen Arthritis, stellt kein einheitliches Krankheitsbild dar. Dies führt bis heute zu Schwierigkeiten bei der Klassifikation. Es sind zumindest zwei Gruppen von Patienten zu unterscheiden: i)die im Kleinkind-/Vorschulalter erkrankten, meist weiblichen, häufig ANA-positiven Patienten, die oft eine Daktylitis und/oder einen Befall kleiner Gelenke zeigen, sowie ii)jene, die im Schulalter erkranken, häufiger eine Enthesitis und/oder einen axialen Gelenkbefall aufweisen und sich damit eher wie eine Spondy

APA, Harvard, Vancouver, ISO, and other styles

33

Collado, P., N. Palmou-Fontana, P. Mesa del Castillo, et al. "POS0752 MUSCULOSKELETAL INVOLVEMENT IMPAIRS QUALITY OF LIFE IN JUVENILE PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 667.1–667. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3892.

Full text

Abstract:

BackgroundJuvenile psoriatic arthritis (JPsA) is one of the least common subtypes of JIA. Information on JPsA is mainly clinical, but scarce regarding the impact of musculoskeletal involvement on children’s quality of life.ObjectivesTo describe the clinical and ultrasound (US) characteristics of children with JPsA, and to assess their impact using a composite quality of life index, the PsAID (Psoriasis Arthritis Impact of Disease).MethodsA multicentre cross-sectional observational study recruited consecutive JPsA patients, from January-2020 to May-2022. Inclusion criteria: 1/ age at onset ≤ 16

APA, Harvard, Vancouver, ISO, and other styles

34

Nikishina, I., S. Arsenyeva, M. Kaleda, et al. "THU0514 BIOLOGICAL THERAPY IN JUVENILE PSORIATIC ARTHRITIS – 15 YEARS OF SINGLE CENTER EXPERIENCE." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 495.2–496. http://dx.doi.org/10.1136/annrheumdis-2020-eular.6366.

Full text

Abstract:

Background:Juvenile psoriatic arthritis (JPsA) is one of the clinical variants of juvenile idiopathic arthritis (JIA), which is often characterized by an unfavorable course, refractory to therapy, requiring the prescription of Biological agents (BA).Objectives:analysis of BA use in patients with JPsA and therapy survival, switching to another line of BA.Methods:the retrospective cohort study included 1095 JIA patients who received BA and were observed in our clinic from 2004 to 2019. All cases of new onset psoriasis were collected; clinical features of disease onset and course, exposure to Met

APA, Harvard, Vancouver, ISO, and other styles

35

Joelianto, Endra, and Alex Dananjaya. "Pemrograman Ladder PLC Pada Otomasi Proses Produksi Bioetanol Berbasis Jala Petri Sinyal Terinterpretasi (JPST)." TEKNIK 41, no. 2 (2020): 152–62. http://dx.doi.org/10.14710/teknik.v0i0.24638.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

LURATI, ALFREDOMARIA, ALESSANDRA SALMASO, VALERIA GERLONI, MAURIZIO GATTINARA, and FLAVIO FANTINI. "Accuracy of Wallace Criteria for Clinical Remission in Juvenile Idiopathic Arthritis: a Cohort Study of 761 Consecutive Cases." Journal of Rheumatology 36, no. 7 (2009): 1532–35. http://dx.doi.org/10.3899/jrheum.080434.

Full text

Abstract:

Objective.To evaluate disease course and clinical usefulness in some categories of juvenile idiopathic arthritis (JIA) by applying newly developed Wallace definitions of remission off drugs.Methods.In a retrospective study, charts of patients with chronic form of primary (idiopathic) arthritis followed from our center since 1970 were reviewed and clinical/laboratory variables were collected for further analysis.Results.The cohort included 761 eligible patients [516 (67.8%) female, 245 (32.2%) male] with JIA. Mean disease onset age (± standard deviation) was 6.25 ± 4.4 years (range 0.5–15.9). D

APA, Harvard, Vancouver, ISO, and other styles

37

Wijayanti, Dyana, Imam Kusmaryono, Hevy Rizqi Maharani, Mohamad Aminudin, Nila Ubaidah, and Mochamad Abdul Basir. "Penggunaan Open Journal System (OJS) bagi Guru SMA Negeri 1 Pegandon." Indonesian Journal of Community Services 5, no. 1 (2023): 20. http://dx.doi.org/10.30659/ijocs.5.1.20-28.

Full text

Abstract:

Guru diwajibkan melaksanakan publikasi pada pangkat tertentu sebagai proses penjaminan kualitas pendidikan. Namun begitu, berbagai kendala dihadapi oleh guru dalam proses publikasi. Salah satu di antaranya adalah adaptasi penggunaan teknologi dalam mengajukan artikel pada laman �Open Journal System�. Tim pengabdian Pendidikan Matematika Unissula menyasar pada masalah tersebut dengan melaksanakan workshop Manajemen Penggunaan Open Journal System (OJS) bagi Guru SMA Negeri 1 Pegandon, Kabupaten Kendal. Kegiatan ini dilaksanakan secara hybrid, baik daring maupun luring. Secara kualitas, beberapa

APA, Harvard, Vancouver, ISO, and other styles

38

Knitza, Johannes, Rachel Knevel, Karim Raza, et al. "Toward Earlier Diagnosis Using Combined eHealth Tools in Rheumatology: The Joint Pain Assessment Scoring Tool (JPAST) Project." JMIR mHealth and uHealth 8, no. 5 (2020): e17507. http://dx.doi.org/10.2196/17507.

Full text

Abstract:

Outcomes of patients with inflammatory rheumatic diseases have significantly improved over the last three decades, mainly due to therapeutic innovations, more timely treatment, and a recognition of the need to monitor response to treatment and to titrate treatments accordingly. Diagnostic delay remains a major challenge for all stakeholders. The combination of electronic health (eHealth) and serologic and genetic markers holds great promise to improve the current management of patients with inflammatory rheumatic diseases by speeding up access to appropriate care. The Joint Pain Assessment Sco

APA, Harvard, Vancouver, ISO, and other styles

39

Ruperto, N., I. Foeldvari, E. Alexeeva, et al. "LB0004 EFFICACY AND SAFETY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS: PRIMARY RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA)." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 201–2. http://dx.doi.org/10.1136/annrheumdis-2021-eular.5038.

Full text

Abstract:

Background:Enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA) are two ILAR categories of juvenile idiopathic arthritis (JIA) and represent paediatric correlates of axial spondyloarthritis (axSpA) and adult psoriatic arthritis (PsA), respectively.1,2 Secukinumab (SEC) has demonstrated efficacy and safety in adult patients (pts) with PsA, ankylosing spondylitis and non-radiographic axSpA.3-5Objectives:Evaluate efficacy and safety of SEC using a flare prevention design in pts with active ERA and JPsA.Methods:This 2-yr study consisted of an open-label (OL) s.c. SEC (75/150

APA, Harvard, Vancouver, ISO, and other styles

40

Baquet-Walscheid, Karoline, Kai Rothaus, Martina Niewerth, Jens Klotsche, Kirsten Minden, and Arnd Heiligenhaus. "Occurrence and Risk Factors of Uveitis in Juvenile Psoriatic Arthritis: Data From a Population-based Nationwide Study in Germany." Journal of Rheumatology, January 15, 2022, jrheum.210755. http://dx.doi.org/10.3899/jrheum.210755.

Full text

Abstract:

Objective Data on uveitis in juvenile psoriatic arthritis ( JPsA), a category of juvenile idiopathic arthritis ( JIA), are scarce. We describe prevalence and risk factors for JPsA-associated uveitis ( JPsA-U). Methods Cross-sectional data from the German National Pediatric Rheumatological Database (2002–2014) were used to characterize JPsA-U and assess risk factors for the development of uveitis. Results Uveitis developed in 6.6% of 1862 patients with JPsA. Patients with JPsA-U were more frequently female (73.0 vs 62.9%, P = 0.03), antinuclear antibody (ANA) positive (60.3 vs 37.0%, P < 0.0

APA, Harvard, Vancouver, ISO, and other styles

41

Low, Jie Man, Kimme L. Hyrich, Coziana Ciurtin, et al. "The impact of psoriasis on wellbeing and clinical outcomes in juvenile psoriatic arthritis." Rheumatology, July 19, 2023. http://dx.doi.org/10.1093/rheumatology/kead370.

Full text

Abstract:

Abstract Objectives Juvenile psoriatic arthritis (JPsA) has varied clinical features that are distinctive to other juvenile idiopathic arthritis (JIA) categories. This study investigates whether such features impact patient-reported and clinical outcomes. Methods Children and young people (CYP) were selected if recruited to the Childhood Arthritis Prospective Study, a UK multicentre JIA inception cohort, between January 2001 and March 2018. At diagnosis, patient/parent-reported outcomes (as age-appropriate) included the parental global assessment (10 cm VAS), functional ability (CHAQ), pain (1

APA, Harvard, Vancouver, ISO, and other styles

42

Brunello, Francesco, Francesca Tirelli, Luca Pegoraro, et al. "New Insights on Juvenile Psoriatic Arthritis." Frontiers in Pediatrics 10 (May 26, 2022). http://dx.doi.org/10.3389/fped.2022.884727.

Full text

Abstract:

Juvenile psoriatic arthritis (JPsA) is a relatively rare condition in childhood as it represents approximately 5% of the whole Juvenile Idiopathic Arthritis (JIA) population. According to International League of Associations of Rheumatology (ILAR) classification, JPsA is defined by the association of arthritis and psoriasis or, in the absence of typical psoriatic lesions, with at least two of the following: dactylitis, nail pitting, onycholysis or family history of psoriasis in a first-degree relative. However, recent studies have shown that this classification system could conceal more homoge

APA, Harvard, Vancouver, ISO, and other styles

43

Nishida, Sakiya, Yoshio Hisata, Aki Yasaka, et al. "Positive association between patient experience of primary care with chronic disease and self‐rated health in a Japanese rural area: A cross‐sectional questionnaire survey using the Japanese primary care assessment tool short form." Journal of General and Family Medicine, July 29, 2024. http://dx.doi.org/10.1002/jgf2.721.

Full text

Abstract:

AbstractBackgroundLow birthrates and an aging society during population decline have brought about labor shortages and increased medical care needs. Medical resources should be distributed appropriately, particularly in rural areas. High‐quality primary care can make the medical system more effective and contribute to rural residents' health. However, there are no reports on the impact of primary care on health in the rural areas of Japan. This study examined the effect of primary care quality on self‐rated health in a rural Japanese area.MethodsWe conducted a cross‐sectional study using a que

APA, Harvard, Vancouver, ISO, and other styles

44

"10.2141/jpsa.2015/02/05." CrossRef Listing of Deleted DOIs 1 (2000). http://dx.doi.org/10.2141/jpsa.2015/02/05.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Nakayama, Gen, Shoichi Masumoto, Junji Haruta, and Tetsuhiro Maeno. "Primary care experiences of family caregivers using the same medical facility as their care recipient or a different facility." Journal of General and Family Medicine, April 18, 2025. https://doi.org/10.1002/jgf2.70000.

Full text

Abstract:

AbstractBackgroundFamily caregivers and care recipients do not always have the same usual source of care, which may create barriers to providing optimal care for caregivers. This study aimed to compare family caregivers' primary care experiences based on whether they used the same medical facility as their care recipient or a different facility.MethodsWe used cross‐sectional data from a survey conducted in Japan in 2020. Participants were family caregivers aged 40–74 years who cared for community‐dwelling adults with chronic conditions. Caregivers' primary care experiences were assessed using

APA, Harvard, Vancouver, ISO, and other styles

46

Abdella, Dina Hamdy Mohammed, Aya Mohamed Rabie Abd Elghany, Sameh Sarsik, Maha Kamal Khallaf, and Shaimaa Abdelmonem Abdelwahab. "Factors predicting juvenile psoriatic arthritis in children with psoriasis." Egyptian Rheumatology and Rehabilitation 52, no. 1 (2025). https://doi.org/10.1186/s43166-025-00344-2.

Full text

Abstract:

Abstract Background Juvenile psoriatic arthritis (JPsA) is one of progressive idiopathic arthritis that affects children with psoriasis. The transition from cutaneous to arthritis development may be linked to genetic and clinical-demographic risk factors. However, the true events responsible for this transition are currently unclear. Thus, this cross-sectional study aimed to evaluate clinical risk factors among children with JPsA that may be involved in arthritis development. 40 children with psoriasis without arthritis (group I) were enrolled in this study, besides 40 children with JPsA (grou

APA, Harvard, Vancouver, ISO, and other styles

47

Iwakuma, Miho, Takuya Aoki, and Mariko Morishita. "Patient experience (PX) among individuals with disabilities in Japan: a mixed-methods study." BMC Primary Care 23, no. 1 (2022). http://dx.doi.org/10.1186/s12875-022-01800-0.

Full text

Abstract:

Abstract Background People with disabilities (PWDs) tend to be disadvantaged in terms of receiving preventive medicine and medical checkups. About 7.6% of the Japanese population is estimated to have a disability. Although patient experience (PX) is an effective measure of patient-centeredness, little is known about the PX of PWDs. The present study aimed to compare the PX of PWDs with those of the non-disabled both quantitatively and qualitatively. Methods The present study involved a questionnaire survey and a free-response question on the survey form. The quantitative part of the study invo

APA, Harvard, Vancouver, ISO, and other styles

48

"APSA/JPSA Exchange Reaches 7th Year." PS: Political Science & Politics 29, no. 04 (1996): 749. http://dx.doi.org/10.1017/s1049096500045935.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Brunner, Hermine I., Ivan Foeldvari, Ekaterina Alexeeva, et al. "Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial." Annals of the Rheumatic Diseases, August 12, 2022, annrheumdis—2022–222849. http://dx.doi.org/10.1136/ard-2022-222849.

Full text

Abstract:

BackgroundTreatment options in patients with enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA) are currently limited. This trial aimed to demonstrate the efficacy and safety of secukinumab in patients with active ERA and JPsA with inadequate response to conventional therapy.MethodsIn this randomised, double-blind, placebo-controlled, treatment-withdrawal, phase 3 trial, biologic-naïve patients (aged 2 to <18 years) with active disease were treated with open-label subcutaneous secukinumab (75/150 mg in patients <50/≥50 kg) in treatment period (TP) 1 up to week 12,

APA, Harvard, Vancouver, ISO, and other styles

50

Qian, Yuli, Louisa Schlachter, Doerthe Eckert, et al. "Extrapolation of Upadacitinib Efficacy in Juvenile Idiopathic Arthritis Leveraging Pharmacokinetics, Exposure–Response Models, and Real‐World Patient Data." Clinical Pharmacology & Therapeutics, September 29, 2024. http://dx.doi.org/10.1002/cpt.3441.

Full text

Abstract:

Juvenile idiopathic arthritis (JIA) is the most prevalent pediatric rheumatic disease. While disease‐modifying antirheumatic drugs (DMARDs), especially biologics, have greatly transformed the management of JIA, there remain some unmet medical needs that require new treatment options. The objective of this work was to describe and apply a modeling and simulation approach to extrapolate upadacitinib efficacy from the adult diseases, rheumatoid arthritis (RA) and psoriatic arthritis (PsA), to their respective pediatric diseases, polyarticular course JIA (pcJIA), and juvenile PsA (JPsA). A populat

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!